BlackRock’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111M | Sell |
2,562,539
-348,290
| -12% | -$15.1M | ﹤0.01% | 1952 |
|
|
2025
Q1 | $109M | Sell |
2,910,829
-134,129
| -4% | -$5.01M | ﹤0.01% | 1916 |
|
|
2024
Q4 | $138M | Buy |
3,044,958
+69,041
| +2% | +$3.13M | ﹤0.01% | 1875 |
|
|
2024
Q3 | $175M | Buy |
2,975,917
+233,368
| +9% | +$13.7M | ﹤0.01% | 1729 |
|
|
2024
Q2 | $108M | Sell |
2,742,549
-67,276
| -2% | -$2.65M | ﹤0.01% | 1961 |
|
|
2024
Q1 | $187M | Buy |
2,809,825
+1,165,788
| +71% | +$77.5M | ﹤0.01% | 1677 |
|
|
2023
Q4 | $45.9M | Sell |
1,644,037
-17,360
| -1% | -$485K | ﹤0.01% | 2481 |
|
|
2023
Q3 | $35.4M | Buy |
+1,661,397
| New | +$35.4M | ﹤0.01% | 2576 |
|